{"title":"La rougeole, une maladie sans histoire ?","authors":"Laurence Monnais","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"76 7","pages":"808-810"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149077281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Alpha-gal syndrome, a new allergy that's causing a stir].","authors":"Evrard Baduel, Magdalena Smilov, Loïc Epelboin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Alpha-gal syndrome (AGS) is an emerging red meat allergy, IgE-mediated, with delayed reactions to a carbohydrate derived from mammals: α-gal (galactose-α-1,3-galactose). Sensitization follows a tick bite. AGS epidemiology remains mysterious, likely due to underreporting and underdiagnosis. AGS disrupts traditional allergy paradigms with its delayed and idiosyncratic manifestations, and the difficulty of allergen eviction due to its pervasiveness in the patients' environment. Many cases have been diagnosed in France over the past 15 years.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"76 7","pages":"785-789"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149077242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Urinary incontinence caused by an overactive bladder].","authors":"Nour Khalil, Claire Richard, Véronique Phé","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Overactive bladder syndrome (OAB) is characterized by urgency, usually associated with increased daytime frequency and nocturia, with or without urgency urinary incontinence. In France, its prevalence is estimated at 14%, with approximately one-third of patients presenting a \"wet\" form, i.e. with urinary leakage. Diagnosis relies on medical history, clinical examination, bladder diaries, symptom scores and, when needed, a pad test. Management should be individualized and starts with lifestyle and behavioral measures, possibly combined with pelvic floor muscle training, local estrogen therapy and transcutaneous tibial nerve stimulation when indicated. Pharmacological treatment includes anticholinergics and β3-agonists (mirabegron and vibegron), and refractory cases may benefit from intradetrusor botulinum toxin injections or sacral neuromodulation. Invasive surgical procedures remain exceptional and are reserved for severe cases, most often in patients with neurological disorders.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"76 7","pages":"734-738"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149077285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Urinary incontinence: so common, yet such a taboo subjec].","authors":"Véronique Phé","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"76 7","pages":"699"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149077275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Urinary incontinence of the older adult].","authors":"Rebecca Haddad, Pierre-Luc Dequirez, Véronique Phé","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The frequency and severity of urinary incontinence (UI) increase with age. Its prevalence varies according to living environment: it is less common among older people living at home than in hospitals or nursing homes. UI is a geriatric syndrome with multiple causes (comorbidities, polypharmacy, etc.) and harmful consequences: reduced quality of life for people and their careers, depression, falls, institutionalization. Diagnosis of UI is based on history-taking and a basic medical check-up, with the aim of ruling out red flags and the causes of transient UI, pointing to an etiology and determining the patient's profile and expectations in terms of management. Treatment may include rehabilitative and behavioural interventions, medication and, in some cases, specialized techniques such as neuromodulation or surgery.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"76 7","pages":"744-748"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149077299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Producing evidence for all: geriatric oncology and the challenge of equity in health care].","authors":"Lynda Sifer-Rivière","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In France, nearly one third of breast cancers occur after the age of 70, yet these patients have long been underrepresented in the clinical trials that inform treatment decisions. This exclusion, rarely made explicit, became embedded in clinical practice. The ASTER 70s trial, published in The Lancet in 2025, provides new evidence. It shows that adjuvant chemotherapy does not improve overall survival in women aged 70 and older, while exposing them to significant toxicity and potential loss of autonomy. This seemingly negative result constitutes a decisive finding: it demonstrates that it is both possible and necessary to generate evidence for populations long excluded from clinical research. It calls for a rethinking of health equity.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"76 7","pages":"715-718"},"PeriodicalIF":0.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149077277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Simon Galmiche, Claire Rouzaud, Olivier Paccoud, Alexandre Alanio, Fanny Lanternier
{"title":"[Invasive mycoses in France: what are the trends?]","authors":"Simon Galmiche, Claire Rouzaud, Olivier Paccoud, Alexandre Alanio, Fanny Lanternier","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The most frequent invasive mycoses in France are candidemia, Pneumocystis jirovecii pneumonia, and invasive aspergillosis. They occur primarily in immunocompromised patients. The risk of Pneumocystis pneumonia and cryptococcosis has notably decreased for people living with HIV through the past two decades. Patients with diabetes or an autoimmune disease represent an increasing proportion of these cases. Mortality of invasive mycoses is still high, particularly in cases of candidemia and invasive aspergillosis. Azole-resistant Aspergillus spp. isolates remain rare in France and the proportion of resistant strains in cases of invasive candidiasis is stable. The emergence of Candida auris, which is associated with outbreaks in healthcare facilities, is closely monitored. Except for candidemia, investigation of predisposing genetic conditions should mainly be conducted when invasive mycosis occurs in patients without any clear risk factor.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"76 6","pages":"673-678"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148431664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Simon Galmiche, Fanny Lanternier, Marie Desnos-Ollivier, Claire Rouzaud, Olivier Lortholary
{"title":"[Candidemia: the most frequent invasive fungal infection in France].","authors":"Simon Galmiche, Fanny Lanternier, Marie Desnos-Ollivier, Claire Rouzaud, Olivier Lortholary","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Candidamia is the most common invasive fungal infection in France. It arises mainly during hospitalization, though community-onset cases can occur. Sepsis is the main clinical presentation. Some rare cases may exhibit signs of secondary septic localizations (endophthalmitis, endocarditis). The diagnosis should be suspected in the presence of risk factors such as immunosuppression, vascular catheters, recent abdominal surgery or antibiotics targeting anaerobic bacteria or with high biliary elimination. It is confirmed from the first positive blood culture. Treatment is based on echinocandins as well as fluconazole in certain specific situations. Global lethality remains high. Preventive measures include limiting the use and duration of vascular catheters and antibiotics.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"76 6","pages":"679-681"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148431815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Syphilis and pregnancy].","authors":"Najeh Hcini, Asmaa Tazi, Romane Cousin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Syphilis is a bacterial infection caused by the species Treponema pallidum subsp. pallidum, transmitted both sexually and vertically. The disease progresses in three distinct stages, with a high risk of contagion in the early stages. The infection has seen a resurgence in several countries around the world and is particularly concerning during pregnancy.Indeed, from the 16th week of gestation, the treponema can cross the placenta and infect the fetus and it can cause placental and/or fetal lesions. Maternal-fetal transmission is more common in the early stages of the disease. The consequences are variable, with polyvisceral involvement (spleen, liver, intestine) and other alterations. The pathological sequence can, in extreme cases, lead to fetal hydrops, premature birth, or even fetal death. Antenatal ultrasound provides evidence for fetal involvement but cannot definitively rule it out. The severity of the abnormalities does not depend on the term of the pregnancy, and there is no teratogenic risk.For pregnancies that result in a live birth, congenital syphilis is often exacerbated by prematurity and hypotrophy, which can lead to complications and sequelae. Following appropriate treatment, clinical, biological, and ultrasound monitoring during pregnancy is indicated. Clinical and biological assessment during the neonatal period is essential.A strategy based on early screening and treatment during pregnancy can help reduce the impact of this pathology on pregnancies worldwide.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"76 6","pages":"630-634"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148431718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}